NASDAQ:MURA Mural Oncology (MURA) Stock Price, News & Analysis $3.63 +0.12 (+3.42%) (As of 10/28/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Mural Oncology Stock (NASDAQ:MURA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mural Oncology alerts:Sign Up Key Stats Today's Range$3.52▼$3.6450-Day Range$3.03▼$3.7252-Week Range$2.88▼$17.00Volume25,100 shsAverage Volume122,387 shsMarket Capitalization$61.86 millionP/E RatioN/ADividend YieldN/APrice Target$16.00Consensus RatingBuy Company OverviewMural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.Read More… War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Mural Oncology Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks74th Percentile Overall ScoreMURA MarketRank™: Mural Oncology scored higher than 74% of companies evaluated by MarketBeat, and ranked 324th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingMural Oncology has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMural Oncology has only been the subject of 2 research reports in the past 90 days.Read more about Mural Oncology's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Mural Oncology are expected to grow in the coming year, from ($7.59) to ($5.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Mural Oncology is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mural Oncology is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMural Oncology has a P/B Ratio of 0.23. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Mural Oncology's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.50% of the float of Mural Oncology has been sold short.Short Interest Ratio / Days to CoverMural Oncology has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Mural Oncology has recently decreased by 15.67%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMural Oncology does not currently pay a dividend.Dividend GrowthMural Oncology does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.50% of the float of Mural Oncology has been sold short.Short Interest Ratio / Days to CoverMural Oncology has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Mural Oncology has recently decreased by 15.67%, indicating that investor sentiment is improving significantly. News and Social Media3.1 / 5News Sentiment0.58 News SentimentMural Oncology has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Mural Oncology this week, compared to 5 articles on an average week.Search Interest2 people have searched for MURA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows3 people have added Mural Oncology to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Mural Oncology insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.06% of the stock of Mural Oncology is held by insiders.Percentage Held by Institutions80.21% of the stock of Mural Oncology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mural Oncology's insider trading history. Receive MURA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address MURA Stock News HeadlinesWest Middle School students and staff rally around Brockton teacher battling breast cancerOctober 28 at 2:20 PM | msn.comPolls open in stable Uruguay in a vote free of political hostility seen elsewhere in the regionOctober 27 at 11:16 AM | msn.comProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.October 29, 2024 | Weiss Ratings (Ad)Lyle Menendez paints mural for California prison beautification program he launched with his brotherOctober 27 at 1:15 AM | apnews.com'We're looking for lumps': Mom, 37, shocked a nipple change was 1st sign of breast cancerOctober 26 at 12:13 AM | yahoo.comHow Dodgers plan to honor Fernando Valenzuela during World SeriesOctober 25, 2024 | msn.comGiant mural painted outside mom’s window of son killed in warOctober 25, 2024 | msn.com'Women on the Journey': Traveling mural hopes to inspire those touched by breast cancerOctober 22, 2024 | msn.comSee More Headlines MURA Stock Analysis - Frequently Asked Questions How have MURA shares performed this year? Mural Oncology's stock was trading at $5.92 on January 1st, 2024. Since then, MURA shares have decreased by 38.7% and is now trading at $3.63. View the best growth stocks for 2024 here. How were Mural Oncology's earnings last quarter? Mural Oncology plc (NASDAQ:MURA) posted its quarterly earnings data on Tuesday, August, 13th. The company reported ($1.86) EPS for the quarter, topping the consensus estimate of ($1.90) by $0.04. How do I buy shares of Mural Oncology? Shares of MURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Mural Oncology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mural Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), General Electric (GE) and Adobe (ADBE). Company Calendar Last Earnings8/13/2024Today10/29/2024Next Earnings (Estimated)12/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MURA Previous SymbolNASDAQ:MURA CUSIPN/A CIK1971543 Webwww.muraloncology.com Phone353-1-905-8020FaxN/AEmployees119Year FoundedN/APrice Target and Rating Average Stock Price Target$16.00 High Stock Price Target$18.00 Low Stock Price Target$13.00 Potential Upside/Downside+340.8%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($10.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-207,450,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-99.54% Return on Assets-83.48% Debt Debt-to-Equity RatioN/A Current Ratio8.65 Quick Ratio8.65 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$15.81 per share Price / Book0.23Miscellaneous Outstanding Shares17,040,000Free Float17,028,000Market Cap$61.86 million OptionableOptionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:MURA) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.